ARBIOS TECHNOLOGIES, INC.

Basic Information

ARBIOS TECHNOLOGIES, INC.
2331 BUCKINGHAM LN
LOS ANGELES, CA, 90077

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. SELECTIVE PLASMA EXCHANGE THERAPY

    Amount: $127,030.00

    DESCRIPTION (provided by applicant): ARBIOS developed a novel liver support therapy (SEPET) to treat patients with severe acute liver failure (ALF). In the absence of any other alternative, such patie ...

    SBIR Phase I 2003 Department of Health and Human Services
  2. DEVELOPMENT OF A NOVEL BIOARTIFICIAL LIVER

    Amount: $177,936.00

    ARBIOS developed a novel hybrid bioartificial live r(HyBAL) to treat patients with liver failure of various etiologies. In the absence of any other alternative, such patients must receive a liver tran ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government